Eleutheroside E, an active component of eleutherococcus senticosus, ameliorates insulin resistance in type 2 diabetic db/db mice

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Ahn, Jiyun ^a   Um, Min Young ^a   Lee, Hyunjung ^a   Jung, Chang Hwa ^a   Heo, Seok Hyun ^b   Ha, Tae Youl ^a  

^a Korea Food Research Institute   (South Korea)

^b Korea Health Supplements Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; CHLOROGENIC ACID; ELEUTHEROCOCCUS SENTICOSUS EXTRACT; ELEUTHEROSIDE E; GLUCOKINASE; GLUCOSE; INSULIN; PLANT GLYCOSIDE; SYRINGIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ELEUTHEROCOCCUS SENTICOSUS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GLYCOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84877284666     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/934183     Document Type: Article

References (23)

1. Moller D. E., New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001 414 6865 821 827 2-s2.0-0035857020 10.1038/414821a (Pubitemid 34000786)
2. Amos A. F., McCarty D. J., Zimmet P., The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Medicine 1997 14 supplement 5 S1 S85
3. Nishibe S., Kinoshita H., Takeda H., Okano G., Phenolic compounds from stem bark of Acanthopanax senticosus and their pharmacological effect in chronic swimming stressed rats. Chemical and Pharmaceutical Bulletin 1990 38 6 1763 1765 2-s2.0-0025029898 (Pubitemid 20265675)
4. Yu C. Y., Kim S. H., Lim J. D., Kim M. J., Chung I. M., Intraspecific relationship analysis by DNA markers and in vitro cytotoxic and antioxidant activity in Eleutherococcus senticosus. Toxicology in Vitro 2003 17 2 229 236 2-s2.0-0037376253 10.1016/S0887-2333(03)00008-0 (Pubitemid 36332245)
5. Schmolz M. W., Sacher F., Aicher B., The synthesis of Rantes, G-CSF, IL-4, IL-5, IL-6, IL-12 and IL-13 in human whole-blood cultures is modulated by an extract from Eleutherococcus senticosus L. roots. Phytotherapy Research 2001 15 3 268 270 2-s2.0-0034998866 10.1002/ptr.746 (Pubitemid 32458640)
6. Niu H. S., Liu I. M., Cheng J. T., Lin C. L., Hsu F. L., Hypoglycemic effect of syringin from Eleutherococcus senticosus in streptozotocin-induced diabetic rats. Planta Medica 2008 74 2 109 113 2-s2.0-40349094851 10.1055/s-2008-1034275 (Pubitemid 351340612)
7. Sun Y. L., Liu L. D., Hong S. K., Eleutherococcus senticosus as a crude medicine: review of biological and pharmacological effects. Journal of Medicinal Plants Research 2011 5 25 7
8. Yamazaki T., Shimosaka S., Sasaki H., Matsumura T., Tukiyama T., Tokiwa T., (+)-Syringaresinol-di-O- β -d-glucoside, a phenolic compound from Acanthopanax senticosus Harms, suppresses proinflammatory mediators in SW982 human synovial sarcoma cells by inhibiting activating protein-1 and/or nuclear factor- B activities. Toxicology in Vitro 2007 21 8 1530 1537 2-s2.0-36048959587 10.1016/j.tiv.2007.04.016 (Pubitemid 350086854)
9. Bu Y., Jin Z. H., Park S. Y., Baek S., Rho S., Ha N., Park S. K., Kim S. Y., Kim H., Siberian ginseng reduces infarct volume in transient focal cerebral ischaemia in Sprague-Dawley rats. Phytotherapy Research 2005 19 2 167 169 2-s2.0-18444371088 10.1002/ptr.1649 (Pubitemid 40646424)
10. Ahn J., Lee H., Kim S., Ha T., Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/ β -catenin signaling. American Journal of Physiology 2010 298 6 C1510 C1516 2-s2.0-77952613059 10.1152/ajpcell.00369.2009
11. Koletsky S., Pathologic findings and laboratory data in a new strain of obese hypertensive rats. American Journal of Pathology 1975 80 1 129 142 2-s2.0-0016750056
12. Chan Y. S., Cheng L. N., Wu J. H., A review of the pharmacological effects of Arctium lappa (burdock). Inflammopharmacology 2011 19 5 245 254
13. Saltiel A. R., New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 2001 104 4 517 529 2-s2.0-0035936763 10.1016/S0092-8674(01)00239-2 (Pubitemid 32201947)
14. Rhodes E. T., Prosser L. A., Hoerger T. J., Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus. Diabetic Medicine 2012 29 4 453 463
15. Yeh G. Y., Eisenberg D. M., Kaptchuk T. J., Phillips R. S., Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003 26 4 1277 1294 2-s2.0-0042668497 10.2337/diacare.26.4.1277 (Pubitemid 36929285)
16. Ong K. W., Hsu A., Tan B. K., Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: a contributor to the beneficial effects of coffee on diabetes. PLoS One 2012 7 3 e32718
17. Sacks D. B., McDonald J. M., The pathogenesis of type II diabetes mellitus: a polygenic disease. American Journal of Clinical Pathology 1996 105 2 149 156 2-s2.0-0030059853 (Pubitemid 26047473)
18. Boden G., Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997 46 1 3 10 2-s2.0-0031014830 (Pubitemid 27009941)
19. Saad M. F., Kahn S. E., Nelson R. G., Pettitt D. J., Knowler W. C., Schwartz M. W., Kowalyk S., Bennett P. H., Porte D., Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1990 70 5 1247 1253 2-s2.0-0025268864
20. Gapp D. A., Leiter E. H., Coleman D. L., Schwizer R. W., Temporal changes in pancreatic islet composition in C57BL/6J-db/db (diabetes) mice. Diabetologia 1983 25 5 439 443 2-s2.0-0021063044 (Pubitemid 14235471)
21. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A. L., Normandin D., Cheng A., Himms-Hagen J., Chan C. C., Ramachandran C., Gresser M. J., Tremblay M. L., Kennedy B. P., Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999 283 5407 1544 1548 2-s2.0-0033525870 10.1126/science.283.5407.1544 (Pubitemid 29133367)
22. DeFronzo R. A., Bonadonna R. C., Ferrannini E., Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992 15 3 318 368 2-s2.0-0026590484
23. Magnusson I., Rothman D. L., Katz L. D., Shulman R. G., Shulman G. I., Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. Journal of Clinical Investigation 1992 90 4 1323 1327 2-s2.0-0026488079